scholarly journals Inflammatory cells in the ascending aortic aneurysm in patients with type 2 diabetes versus patients with hypertension

Author(s):  
Aleksandra Milutinović ◽  
Ruda Zorc-Pleskovič

Aortic aneurysms occur relatively frequently in the ascending thoracic aorta, but are rarely seen in patients with type 2 diabetes. Our aim was to evaluate inflammatory cell infiltration in the ascending aortic aneurysm wall in patients with diabetes without arterial hypertension (DM2 group, N=6) versus hypertensive non-diabetic patients (AH group, N=34). For histologic analysis, the sections were stained with hematoxylin-eosin and Movat pentachrome. The immunohistochemical staining was used to analyze the infiltration of pro-inflammatory (CD68) and anti-inflammatory macrophages (CD163), T helper (CD4) and T killer cells (CD8), and B (CD79a) and plasma cells (CD138) in all three layers of aneurysms of both groups. The statistical significance of the differences between groups was evaluated by ANOVA and the Welch test. In comparison to the AH group, the DM2 group developed less severe infiltration of pro-inflammatory macrophages (P=0.004) and B cells (P=0.025) in the tunica intima, and tunica media (P=0.049, P=0.007, respectively), and fewer plasma cells in the tunica media (P=0.024) and tunica adventitia (P=0.017). We found no significant differences in the number of T helper, T killer cells, and anti-inflammatory macrophages and in the amount of collagen and elastic fibers, ground substance, and smooth muscle cells in all three layers of the vessel wall. Except in tunica adventitia of DM2 group, there were more collagen fibers overall (P=0.025).  Thus, we conclude that the histological structure of the aneurysm in diabetics without hypertension is almost the same as in hypertensive patients without diabetes. Diabetics had significantly less inflammatory infiltration in all three layers of the vessel wall, and more collagen fibers in tunica adventitia.

2013 ◽  
Vol 02 (04) ◽  
pp. 290-295 ◽  
Author(s):  
Mohamed Ahmed Ali ◽  
Yasar A Ahmed ◽  
Abubaker Ibrahim

AbstractMultiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematological cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.


2017 ◽  
Author(s):  
Tamer Havva Gonca ◽  
Ozge Telci Caklili ◽  
Ilkay Kartal ◽  
Kagan Gungor ◽  
Hasan Huseyin Mutlu
Keyword(s):  
T Helper ◽  

2013 ◽  
Vol 208 (5) ◽  
pp. 739-748 ◽  
Author(s):  
Nathella Pavan Kumar ◽  
Rathinam Sridhar ◽  
Vaithilingam V. Banurekha ◽  
Mohideen S. Jawahar ◽  
Thomas B. Nutman ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Zeinab A. Issa ◽  
Mira S. Zantout ◽  
Sami T. Azar

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.


Sign in / Sign up

Export Citation Format

Share Document